Cargando…
Identification of Sorafenib as a Treatment for Type 1 Diabetes
Th1 cell activation is considered a key mediator of the pathogenesis of type 1 diabetes. Targeting IL-12-induced Th1 cell differentiation seems to be an effective way to block the development of type 1 diabetes. However, given the critical function of Th1 in the immune system, the potential side eff...
Autores principales: | Zeng, Qin, Song, Jianfeng, Wang, Dandan, Sun, Xiaoxiao, Xiao, Yalun, Zhang, Haowei, Xiao, Yang, Zhou, Zhiguang, Deng, Tuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886732/ https://www.ncbi.nlm.nih.gov/pubmed/35242127 http://dx.doi.org/10.3389/fimmu.2022.740805 |
Ejemplares similares
-
Metabolic effects of CCL5 deficiency in lean and obese mice
por: Zhou, Hui, et al.
Publicado: (2023) -
A Unique Population: Adipose-Resident Regulatory T Cells
por: Zeng, Qin, et al.
Publicado: (2018) -
Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes
por: Yin, Wenfeng, et al.
Publicado: (2023) -
Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes
por: Tan, Tingting, et al.
Publicado: (2022) -
Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)